What happens when you take omeprazole with magnesium?
Omeprazole shuts down gastric acid production, but its effect on magnesium happens further downstream in the small intestine. Magnesium is absorbed by two routes: passive paracellular diffusion (the bulk pathway) and active transcellular transport through TRPM6 and TRPM7 channels in the small bowel. Long-term PPI use appears to impair the active TRPM6/TRPM7 transport, possibly through changes in intestinal pH and altered protein expression. The passive pathway can usually compensate, but in some patients it cannot, and serum magnesium drops.
This is not a simple absorption-blocking interaction like calcium or iron. It is an acquired functional defect in active magnesium uptake that develops over months to years of chronic acid suppression. Some patients are highly susceptible; others on the same dose for the same duration never develop it. Genetic variation in TRPM6 is suspected.
Why is this important?
In March 2011, the FDA issued a formal Drug Safety Communication warning that prescription PPIs can cause hypomagnesemia, typically after more than a year of use, with some cases occurring after just 3 months. The agency reviewed 38 cases from the FDA Adverse Event Reporting System and 23 from the medical literature. The clinical consequences are serious: muscle spasms (tetany), abnormal heart rhythms (including QT prolongation and torsades de pointes), seizures, and in severe cases hypocalcemia and hypokalemia that are refractory to replacement until the magnesium is corrected.
The risk goes up considerably when omeprazole is combined with other magnesium-wasting drugs: loop diuretics (furosemide), thiazide diuretics (hydrochlorothiazide), digoxin, certain chemotherapy agents (cisplatin), and aminoglycoside antibiotics. The combination of a PPI plus a diuretic in an older adult is a classic setup for severe hypomagnesemia.
A critical clinical feature: in roughly 25% of severe cases, oral and even intravenous magnesium replacement is insufficient. Serum magnesium only normalizes after the PPI is stopped, sometimes taking weeks.
What should you do?
- Baseline and periodic monitoring. The FDA recommends a serum magnesium level before starting long-term PPI therapy and periodically thereafter, especially if you also take diuretics, digoxin, or other magnesium-depleting drugs.
- Symptoms to watch for. Muscle cramps, twitching, tremor, weakness, fatigue, palpitations, dizziness on standing, numbness in hands and feet, and seizures. These can be subtle and progressive.
- Supplement intelligently. Magnesium glycinate (200-400 mg elemental daily) is well-tolerated and well-absorbed. Magnesium citrate is also good. Magnesium oxide is poorly absorbed and tends to cause diarrhea. Avoid relying solely on multivitamins, which usually contain too little magnesium to matter.
- Talk to your doctor about deprescribing. Many long-term PPI prescriptions were never reviewed. If your reflux is well-controlled, ask about stepping down to an H2 blocker (famotidine) or on-demand use only.
- Do not ignore tingling and cramps. These can be early signs of hypomagnesemia. Severe cases present with cardiac arrhythmia and seizures; do not wait that long.
Which specific products are affected?
The 2011 FDA warning covered eight prescription PPIs: omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole (Prevacid), dexlansoprazole (Dexilant), pantoprazole (Protonix), rabeprazole (AcipHex), omeprazole/sodium bicarbonate (Zegerid), and naproxen/esomeprazole (Vimovo). Over-the-counter PPI products at lower doses for shorter durations (e.g. Prilosec OTC 20 mg for 14 days) were not implicated in the original warning, but extended self-treatment beyond labeled duration carries similar risk.
On the supplement side, any oral magnesium supplement may help maintain levels: magnesium glycinate, citrate, malate, threonate, lactate, chloride, or sulfate. Avoid magnesium oxide as a primary supplement because of poor bioavailability. In severe deficiency, intravenous magnesium sulfate is given in hospital, but recurrence is the rule unless the PPI is stopped.
The bottom line
Long-term omeprazole and other PPIs can cause hypomagnesemia, a potentially serious deficiency that the FDA formally warned about in 2011. The mechanism is impaired active intestinal magnesium absorption, and the consequences can include arrhythmias, seizures, and tetany. If you take a PPI for more than a year, or if you also take a diuretic or digoxin, get your serum magnesium checked. Supplement magnesium glycinate or citrate daily for maintenance, and watch for muscle cramps, twitching, palpitations, or unexplained fatigue. In severe or refractory cases, the PPI itself must be discontinued for magnesium to normalize. Do not stop omeprazole abruptly; work with your prescriber to taper.